1. NCMP-04. COMBINATION BRAF/MEK INHIBITION IMPROVES SURVIVAL WITH LEPTOMENINGEAL DISEASE FROM MELANOMA IN A SINGLE INSTITUTIONAL REVIEW AT MOFFITT CANCER CENTER. (14th November 2022) Authors: Wallace, Gerald; Kundalia, Ronak; Imran, Amna; Smalley, Inna; Pina, Yolanda; Forsyth, Peter Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗